Log In
Print
BCIQ
Print
Print this Print this
 

clonidine topical gel, clonidine (formerly ARC-4558)

  Manage Alerts
Collapse Summary General Information
Company Arcion Therapeutics Inc.
DescriptionTopical 0.1% gel formulation of clonidine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetic neuropathy
Indication DetailsTreat painful diabetic neuropathy (PDN)
Regulatory Designation

U.S. - Fast Track (Treat painful diabetic neuropathy (PDN))

Partner

BioDelivery Sciences International Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today